Medical Marijuana Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL MEDICAL MARIJUANA INDUSTRY

2.1 Summary about Medical Marijuana Industry

2.2 Medical Marijuana Market Trends

2.2.1 Medical Marijuana Production & Consumption Trends

2.2.2 Medical Marijuana Demand Structure Trends

2.3 Medical Marijuana Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Cannabis Plant Dry Goods

4.2.2 Cannabis Resin

4.2.3 Cannabis Oil

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Chronic Pain

4.3.2 Arthritis

4.3.3 Migraine

4.3.4 Cancer

4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Cannabis Plant Dry Goods

5.2.2 Cannabis Resin

5.2.3 Cannabis Oil

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Chronic Pain

5.3.2 Arthritis

5.3.3 Migraine

5.3.4 Cancer

5.3.5 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Cannabis Plant Dry Goods

6.2.2 Cannabis Resin

6.2.3 Cannabis Oil

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Chronic Pain

6.3.2 Arthritis

6.3.3 Migraine

6.3.4 Cancer

6.3.5 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Cannabis Plant Dry Goods

7.2.2 Cannabis Resin

7.2.3 Cannabis Oil

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Chronic Pain

7.3.2 Arthritis

7.3.3 Migraine

7.3.4 Cancer

7.3.5 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Cannabis Plant Dry Goods

8.2.2 Cannabis Resin

8.2.3 Cannabis Oil

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Chronic Pain

8.3.2 Arthritis

8.3.3 Migraine

8.3.4 Cancer

8.3.5 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Cannabis Plant Dry Goods

9.2.2 Cannabis Resin

9.2.3 Cannabis Oil

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Chronic Pain

9.3.2 Arthritis

9.3.3 Migraine

9.3.4 Cancer

9.3.5 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Cara Therapeutics

10.1.2 Cannabis Sativa

10.1.3 CannaGrow Holdings

10.1.4 United Cannabis

10.1.5 Growblox Sciences

10.1.6 GreenGro Technologies

10.1.7 GW Pharmaceuticals

10.1.8 Lexaria Corp

10.1.9 MMJ America

10.2 Medical Marijuana Sales Date of Major Players (2017-2020e)

10.2.1 Cara Therapeutics

10.2.2 Cannabis Sativa

10.2.3 CannaGrow Holdings

10.2.4 United Cannabis

10.2.5 Growblox Sciences

10.2.6 GreenGro Technologies

10.2.7 GW Pharmaceuticals

10.2.8 Lexaria Corp

10.2.9 MMJ America

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Medical Marijuana Product Type Overview

Table Medical Marijuana Product Type Market Share List

Table Medical Marijuana Product Type of Major Players

Table Brief Introduction of Cara Therapeutics

Table Brief Introduction of Cannabis Sativa

Table Brief Introduction of CannaGrow Holdings

Table Brief Introduction of United Cannabis

Table Brief Introduction of Growblox Sciences

Table Brief Introduction of GreenGro Technologies

Table Brief Introduction of GW Pharmaceuticals

Table Brief Introduction of Lexaria Corp

Table Brief Introduction of MMJ America

Table Products & Services of Cara Therapeutics

Table Products & Services of Cannabis Sativa

Table Products & Services of CannaGrow Holdings

Table Products & Services of United Cannabis

Table Products & Services of Growblox Sciences

Table Products & Services of GreenGro Technologies

Table Products & Services of GW Pharmaceuticals

Table Products & Services of Lexaria Corp

Table Products & Services of MMJ America

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Medical Marijuana Market Forecast (Million USD) by Region 2021f-2026f

Table Global Medical Marijuana Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Medical Marijuana Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Medical Marijuana Market Forecast (Million USD) Share by Demand 2021f-2026f